Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7850 | 1243 | 36.1 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASPIRIN RESISTANCE | Author keyword | 325 | 79% | 17% | 208 |
2 | PFA 100 | Author keyword | 48 | 49% | 6% | 72 |
3 | THROMBOSTAT | Author keyword | 19 | 76% | 1% | 13 |
4 | PLATELET FUNCTION | Author keyword | 11 | 12% | 7% | 89 |
5 | PLATELET FUNCTION TESTS | Author keyword | 11 | 26% | 3% | 35 |
6 | ACETYLSALICYLIC ACID RESISTANCE | Author keyword | 9 | 83% | 0% | 5 |
7 | ASPIRIN RESPONSIVENESS | Author keyword | 9 | 83% | 0% | 5 |
8 | PFA 100 R | Author keyword | 8 | 45% | 1% | 14 |
9 | PLATELET FUNCTION ASSAYS | Author keyword | 6 | 80% | 0% | 4 |
10 | ASPIRIN NON RESPONSIVENESS | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASPIRIN RESISTANCE | 325 | 79% | 17% | 208 | Search ASPIRIN+RESISTANCE | Search ASPIRIN+RESISTANCE |
2 | PFA 100 | 48 | 49% | 6% | 72 | Search PFA+100 | Search PFA+100 |
3 | THROMBOSTAT | 19 | 76% | 1% | 13 | Search THROMBOSTAT | Search THROMBOSTAT |
4 | PLATELET FUNCTION | 11 | 12% | 7% | 89 | Search PLATELET+FUNCTION | Search PLATELET+FUNCTION |
5 | PLATELET FUNCTION TESTS | 11 | 26% | 3% | 35 | Search PLATELET+FUNCTION+TESTS | Search PLATELET+FUNCTION+TESTS |
6 | ACETYLSALICYLIC ACID RESISTANCE | 9 | 83% | 0% | 5 | Search ACETYLSALICYLIC+ACID+RESISTANCE | Search ACETYLSALICYLIC+ACID+RESISTANCE |
7 | ASPIRIN RESPONSIVENESS | 9 | 83% | 0% | 5 | Search ASPIRIN+RESPONSIVENESS | Search ASPIRIN+RESPONSIVENESS |
8 | PFA 100 R | 8 | 45% | 1% | 14 | Search PFA+100+R | Search PFA+100+R |
9 | PLATELET FUNCTION ASSAYS | 6 | 80% | 0% | 4 | Search PLATELET+FUNCTION+ASSAYS | Search PLATELET+FUNCTION+ASSAYS |
10 | ASPIRIN NON RESPONSIVENESS | 6 | 100% | 0% | 4 | Search ASPIRIN+NON+RESPONSIVENESS | Search ASPIRIN+NON+RESPONSIVENESS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBOXANE BIOSYNTHESIS | 51 | 39% | 8% | 105 |
2 | ASPIRIN RESISTANCE | 47 | 30% | 10% | 130 |
3 | PLATELET FUNCTION TESTS | 41 | 65% | 3% | 39 |
4 | INCREASED PLATELET SENSITIVITY | 28 | 81% | 1% | 17 |
5 | CLOSURE TIME | 28 | 69% | 2% | 24 |
6 | NONRESPONDER | 25 | 71% | 2% | 20 |
7 | PRIMARY HEMOSTASIS | 24 | 41% | 4% | 46 |
8 | FUNCTION ANALYZER | 24 | 38% | 4% | 50 |
9 | FUNCTION ANALYZER PFA 100R | 23 | 56% | 2% | 28 |
10 | PFA 100TM SYSTEM | 18 | 65% | 1% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events - A systematic review and meta-analysis | 2007 | 233 | 35 | 69% |
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review | 2007 | 148 | 49 | 86% |
Aspirin resistance | 2006 | 254 | 92 | 59% |
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100 - A systematic review | 2008 | 86 | 105 | 82% |
Platelet function analyzer (PFA)-100 (R) closure time in the evaluation of platelet disorders and platelet function | 2006 | 184 | 78 | 65% |
Mechanisms of aspirin resistance | 2014 | 12 | 117 | 30% |
Aspirin resistance: Effect of clinical, biochemical and genetic factors | 2011 | 36 | 140 | 58% |
Pharmacogenetics of aspirin resistance: a comprehensive systematic review | 2008 | 81 | 50 | 58% |
The role of aspirin in cardiovascular prevention - Implications of aspirin resistance | 2008 | 123 | 109 | 39% |
Clinical Utility of the PFA-100 | 2008 | 90 | 142 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIAC THROMBOSIS UNIT | 4 | 67% | 0.3% | 4 |
2 | CLIN SOUTH BLDG | 4 | 75% | 0.2% | 3 |
3 | NONINVAS CARDIOL HYPERTENS | 4 | 56% | 0.4% | 5 |
4 | HEART LARGE VESSELS ATTILIO REALE | 3 | 100% | 0.2% | 3 |
5 | HEMATOL MALAD SANG | 3 | 50% | 0.3% | 4 |
6 | PERIOPERAT GENOM | 3 | 42% | 0.4% | 5 |
7 | HAEMOSTASIS HAEMOSTAT DISORDERS | 3 | 18% | 1.0% | 13 |
8 | ASSAY DEV HEMOSTASIS | 2 | 67% | 0.2% | 2 |
9 | CARDIAC SURG INTENS CARE | 2 | 50% | 0.2% | 3 |
10 | ATHEROSCLEROSIS THROMBOSIS | 2 | 43% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270277 | ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM |
2 | 0.0000249923 | CLOPIDOGREL//PRASUGREL//TICAGRELOR |
3 | 0.0000183459 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
4 | 0.0000144312 | 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT |
5 | 0.0000078580 | VESSEL WALL INJURY//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//CLIN BIOCHEM IMMUNOHEMATOL |
6 | 0.0000077238 | TRIFLUSAL//HTB//CAS 322 79 2 |
7 | 0.0000071382 | MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES |
8 | 0.0000071057 | TRANSIENT ISCHEMIC ATTACK//ABCD2 SCORE//TIA |
9 | 0.0000069910 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |
10 | 0.0000067907 | BRIDGING ANTICOAGULATION//BRIDGING THERAPY//BLOOD THINNERS |